BBIO - BridgeBio Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 30.80%
S&P500 52-Week Change 38.32%
52 Week High 348.36
52 Week Low 314.23
50-Day Moving Average 331.29
200-Day Moving Average 331.60

Share Statistics

Avg Vol (3 month) 31.05M
Avg Vol (10 day) 3913.75k
Shares Outstanding 5121.37M
Float 41.22M
% Held by Insiders 112.48%
% Held by Institutions 196.07%
Shares Short (May 14, 2020) 48.64M
Short Ratio (May 14, 2020) 415.81
Short % of Float (May 14, 2020) 417.20%
Short % of Shares Outstanding (May 14, 2020) 47.12%
Shares Short (prior month Apr 14, 2020) 48.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-946.81%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)26.74M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)38.06M
EBITDA -252.47M
Net Income Avi to Common (ttm)-239.06M
Diluted EPS (ttm)-4.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)536.05M
Total Cash Per Share (mrq)4.34
Total Debt (mrq)75.02M
Total Debt/Equity (mrq)14.31
Current Ratio (mrq)14.00
Book Value Per Share (mrq)3.92

Cash Flow Statement

Operating Cash Flow (ttm)-223.8M
Levered Free Cash Flow (ttm)N/A